mutations and complicated kar yotype. It follows a linear evolution from the CLL clone through the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding areas from the genome, are predominantly located in Lively promoters or enhancers, and modify the binding web sites of several transcription c